Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir
Crossref DOI link: https://doi.org/10.1007/s13340-017-0303-5
Published Online: 2017-01-18
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iwasaki, Shingo
Kozawa, Junji
Kimura, Takekazu
Fukui, Kenji
Iwahashi, Hiromi
Imagawa, Akihisa http://orcid.org/0000-0002-4213-3229
Shimomura, Iichiro
Funding for this research was provided by:
Novo Nordisk
Eli Lilly
Sanofi
License valid from 2017-01-18